Wednesday, 2 October 2019 | 17.30-19.30 | Conference Centre Room 2
Blood is a scarce, precious and sometimes overused resource. Against a backdrop of waning blood supplies and concern about transmissible diseases, the European Commission is considering a review of the EU Blood Directive. It is timely to reflect on current blood policies and how to improve patient care while building sustainable healthcare models.
Patient Blood Management (PBM) is a paradigm shift, disrupting standard healthcare practices. It has the potential for re-imagining hospital systems and the patient journey by reducing the need for transfusions - thus making blood available to those who need it most, improving patient outcomes and reducing healthcare costs. A multi-sectoral panel of experts will discuss blood policy, PBM and their impact on healthcare systems. Participants will be encouraged to reflect on existing policies, the role of patients and how to drive PBM policy uptake.
AXEL HOFMANN, Assistant Professor, University of Western Australia, Curtin University Australia, University Hospital Zurich, Switzerland & Trustee, International Foundation for Patient Blood Management
CHRISTOPH ZENGER, President, International Foundation for Patient Blood Management
ELVIRA BISBE VIVES, Doctor of Anaesthesiology, University Hospital Mar-Esperanca, Hospital del Mar Medical Research Institute
DANNY HAVENITH, CEO, MercurHosp & Board Member, Belgische Vereniging van Ziekenhuisdirecteurs (BVZD)/ Association Belge des Directeurs d'Hôpitaux (L'ABDH)
ANNA MEZZACASA, Medical Lead Iron Franchise, Vifor Pharma